| Literature DB >> 30867458 |
E Alkan1, T P Taporoski1,2,3, A Sterr1, M von Schantz1,3, H Vallada3, J E Krieger2, A C Pereira2, R Alvim2, A R V R Horimoto2, S Pompéia4, A B Negrão2, S L H Evans5.
Abstract
Cardiometabolic risk factors influence white matter hyperintensity (WMH) development: in metabolic syndrome (MetS), higher WMH load is often reported but the relationships between specific cardiometabolic variables, WMH load and cognitive performance are uncertain. We investigated these in a Brazilian sample (aged 50-85) with (N = 61) and without (N = 103) MetS. Stepwise regression models identified effects of cardiometabolic and demographic variables on WMH load (from FLAIR MRI) and verbal recall performance. WMH volume was greater in MetS, but verbal recall performance was not impaired. Age showed the strongest relationship with WMH load. Across all participants, systolic blood pressure (SBP) and fasting blood glucose were also contributors, and WMH volume was negatively associated with verbal recall performance. In non-MetS, higher HbA1c, SBP, and number of MetS components were linked to poorer recall performance while higher triglyceride levels appeared to be protective. In MetS only, these relationships were absent but education exerted a strongly protective effect on recall performance. Thus, results support MetS as a construct: the clustering of cardiometabolic variables in MetS alters their individual relationships with cognition; instead, MetS is characterised by a greater reliance on cognitive reserve mechanisms. In non-MetS, strategies to control HbA1c and SBP should be prioritised as these have the largest impact on cognition.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30867458 PMCID: PMC6416472 DOI: 10.1038/s41598-019-40630-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Participant characteristics (All, non-MetS, MetS), p values from t-tests comparing subgroups (non-MetS vs. MetS).
| All ( | Non-MetS ( | MetS ( |
| |
|---|---|---|---|---|
| Age, M (SD) | 60.09 ± 7.89 | 59.70 ± 7.82 | 60.75 ± 8.03 | 0.409 |
| Female (N, %) | 97 (59.1%) | 58 (56.3%) | 39 (63.9%) | 0.337 |
| Education (years) | 6.30 ± 4.40 | 6.40 ± 4.56 | 6.15 ± 4.16 | 0.726 |
| Socioeconomic status | 1.92 ± 0.53 | 1.92 ± 0.63 | 1.91 ± 0.29 | 0.883 |
| Body Mass Index (kg/m2) | 27.18 ± 4.66 | 26.28 ± 4.74 | 28.69 ± 4.13 | <0.001 |
| Waist Circumference (cm) | 95.26 ± 11.07 | 93.02 ± 11.08 | 99.03 ± 10.05 | <0.001 |
| Systolic BP (mmHg) | 129.60 ± 16.88 | 125.59 ± 14.70 | 136.36 ± 18.23 | <0.001 |
| Diastolic BP (mmHg) | 79.53 ± 19.16 | 78.41 ± 23.18 | 81.43 ± 8.85 | 0.331 |
| Fasting Blood Glucose (mM) | 5.62 ± 1.9 | 5.10 ± 1.0 | 6.40 ± 2.7 | <0.001 |
| Total Cholesterol (mM) | 5.41 ± 1.1 | 5.25 ± 0.9 | 5.66 ± 1.10 | 0.013 |
| Triglyceride (mM) | 1.72 ± 1.0 | 1.35 ± 0.6 | 2.39 ± 1.2 | <0.001 |
| HDL-C (mM) | 1.21 ± 0.3 | 1.27 ± 0.3 | 1.11 ± 0.2 | <0.001 |
| LDL-C (mM) | 3.40 ± 0.9 | 3.36 ± 0.8 | 3.49 ± 1.0 | 0.353 |
| HbA1c | 6.07 ± 1.2 | 5.80 ± 0.7 | 6.53 ± 1.69 | <0.001 |
| Smokers (N, %) (Current Smokers) | 18 (11.8%) | 11 (11.5%) | 7 (12.3%) | 0.979 |
|
| ||||
| Elevated BP | 69 (54.5%) | 30 (29.1%) | 39 (63.9%) | <0.001 |
| Elevated Fasting Blood Glucose | 29 (17.7%) | 6 (5.8%) | 23 (37.7%) | <0.001 |
| Elevated Triglyceride | 68 (41.5%) | 18 (17.5%) | 50 (82.0%) | <0.001 |
| Low HDL-C | 90 (54.9%) | 38 (36.9%) | 52 (85.2%) | <0.001 |
| Abdominal Obesity | 85 (53.4%) | 41 (39.8%) | 44 (72.1%) | <0.001 |
| 0.98 ± 1.9 | 0.73 ± 1.3 | 1.39 ± 2.6 | 0.034 | |
| 4.86 ± 4.6 | 4.43 ± 4.0 | 5.59 ± 5.6 | 0.122 | |
| 18.04 ± 4.1 | 18.15 ± 4.2 | 17.9 ± 3.9 | 0.669 | |
| 4.37 ± 1.5 | 4.44 ± 1.6 | 4.28 ± 1.4 | 0.527 | |
| 3.08 ± 1.6 | 2.96 ± 1.7 | 3.28 ± 1.4 | 0.225 | |
Abbreviations: HbA1c, Haemoglobin A1c; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; WMH, White Matter Hyperintensities; M (SD), mean (standard deviation).
Linear regression analyses for all subjects, and non-MetS, MetS subgroups.
| WMH Volume | WMH Number | WL: Total | WL: Immediate | WL: Learning | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Non- Mets | With MetS | All | Non- Mets | With MetS | All | Non- Mets | With MetS | All | Non- Mets | With MetS | All | Non- Mets | With MetS | |
| WMH Volume | — | — | — | 0.797** | 0.774** | 0.822** | −0.166* | −0.195* | −0.154 | −0.120 | −0.166 | −0.080 | −0.081 | −0.060 | −0.164 |
| WMH Number | — | — | — | — | — | — | −0.086 | −0.100 | −0.064 | −0.069 | −0.076 | −0.050 | −0.056 | −0.070 | −0.074 |
| No. of Components | 0.186* | 0.035 | 0.157 | 0.175* | 0.034 | 0.285* | −0.106 | −0.178 | −0.051 | −0.115 | −0.123 | −0.145 | 0.109 | −0.006 | 0.209 |
| Years of education | −0.142 | −0.141 | −0.157 | −0.079 | −0.036 | −0.133 | 0.101 | 0.114 | 0.074 | −0.004 | 0.063 | −0.150 | 0.197* | 0.125 | 0.383** |
| Age | 0.422** | 0.466** | 0.417** | 0.454** | 0.446** | 0.467** | −0.111 | −0.105 | −0.117 | −0.066 | −0.110 | 0.024 | −0.094 | −0.238 | −0.235 |
Note —Data are Pearson correlation coefficients (r). Abbreviations: WMH White Matter Hyperintensities, MetS Metabolic Syndrome **p < 0.01. *p < 05.
Variables explaining significant variance, identified by the stepwise multiple regression models, constructed separately for all subjects, MetS and non-MetS subgroups.
| Dependent Variable | All Subjects | With MetS | Without MetS |
|---|---|---|---|
| WMH Volume | Age (R² = 0.178, β = 0.359, p = 0.000) | Age (R² = 0.173, β = 0.417, p = 0.000) | Age (R² = 0.217, β = 0.466, p = 0.000) |
| WMH Number | Age (R² = 0.206, β = 0.433, p = 0.000) | Age (R² = 0.218, β = 0.467, p = 0.000) | Age (R² = 0.199, β = 0.446, p = 0.000) |
| Word List: Total | WMH volume (R² = 0.027, β = −0.166, p = 0.000) | None | HbA1c (R² = 0.038, β = −0.178, p = 0.050) |
| Word List: Immediate | HbA1c (R² = 0.031, β = −0.175, p = 0.027) | None | None |
| Word List: Learning | Education (R² = 0.039, β = 0.197, p = 0.012) | Education (R² = 0.146, β = 0.383, p = 0.003) | Triglyceride (R² = 0.041, β = 0.195, p = 0.040) |
SBP, Systolic BP.